General comments: We provide these summary data in the spirit of transparency and open data sharing. Given the relatively small number of reported cases and preliminary nature of these reports, we do not recommend these data be used to inform clinical decisions at this time. Additionally, as many mild cases of COVID-19 do not undergo testing, these data may over-represent more severe cases in which COVID-19 testing was performed. Please note that rows and columns from tables below may not add up to the exact number of total reported cases due to incomplete data and/or non-mutually exclusive variables.
Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.
* Countries not included in this table have not reported any cases to SECURE-IBD
Cases reported by state (U.S. only)*
state
N
ALABAMA
24
ARIZONA
20
ARKANSAS
14
CALIFORNIA
135
COLORADO
17
CONNECTICUT
33
DELAWARE
4
DISTRICT OF COLUMBIA
10
FLORIDA
126
GEORGIA
69
IDAHO
9
ILLINOIS
201
INDIANA
14
IOWA
23
KANSAS
15
KENTUCKY
14
LOUISIANA
45
MAINE
2
MARYLAND
55
MASSACHUSETTS
72
MICHIGAN
54
MINNESOTA
81
MISSISSIPPI
29
MISSOURI
46
MONTANA
12
NEBRASKA
47
NEVADA
6
NEW HAMPSHIRE
4
NEW JERSEY
91
NEW MEXICO
1
NEW YORK
303
NORTH CAROLINA
96
NORTH DAKOTA
3
OHIO
150
OKLAHOMA
16
OREGON
12
PENNSYLVANIA
99
RHODE ISLAND
26
SOUTH CAROLINA
23
SOUTH DAKOTA
3
TENNESSEE
62
TEXAS
93
UTAH
19
VERMONT
5
VIRGINIA
51
WASHINGTON
38
WEST VIRGINIA
2
WISCONSIN
64
GUAM
2
PUERTO RICO
7
NA
76
* States not included in this table have not reported any cases to SECURE-IBD
Cases and outcomes by patient characteristics
Characteristic
Total N
Outpatient only (n, %)
Hospitalized (n, %)
ICU (n, %)
Ventilator (n, %)
Death (n, %)
ICU/Ventilator/Death (n, %)
Overall
7,038
5,923
84%
1,013
14%
192
3%
148
2%
107
2%
268
4%
Age
0-9 years
46
41
89%
3
7%
2
4%
2
4%
0
0%
2
4%
10-19 years
764
720
94%
35
5%
6
1%
2
0%
0
0%
6
1%
20-29 years
1,451
1,331
92%
103
7%
4
0%
1
0%
1
0%
5
0%
30-39 years
1,473
1,313
89%
134
9%
16
1%
8
1%
4
0%
17
1%
40-49 years
1,272
1,093
86%
166
13%
26
2%
18
1%
4
0%
29
2%
50-59 years
1,051
821
78%
218
21%
44
4%
41
4%
14
1%
61
6%
60-69 years
567
371
65%
183
32%
58
10%
48
8%
30
5%
69
12%
70-79 years
233
127
55%
100
43%
27
12%
20
9%
24
10%
42
18%
>=80 years
142
71
50%
67
47%
7
5%
8
6%
29
20%
35
25%
Sex
Male
3,377
2,765
82%
568
17%
106
3%
82
2%
74
2%
155
5%
Female
3,536
3,051
86%
432
12%
83
2%
63
2%
33
1%
110
3%
Other
3
2
67%
0
0%
0
0%
0
0%
0
0%
0
0%
Disease type
Crohns disease
4,019
3,483
87%
482
12%
82
2%
68
2%
48
1%
115
3%
Ulcerative Colitis/unspecified
2,970
2,401
81%
525
18%
108
4%
78
3%
58
2%
151
5%
IBD Disease
Activity
Remission
3,898
3,374
87%
491
13%
97
2%
80
2%
52
1%
138
4%
Mild
1,470
1,264
86%
186
13%
30
2%
22
1%
20
1%
45
3%
Moderate/Severe
1,302
991
76%
289
22%
55
4%
38
3%
29
2%
73
6%
Unknown
368
294
80%
47
13%
10
3%
8
2%
6
2%
12
3%
Smoking
Current smoker
288
243
84%
45
16%
6
2%
2
1%
5
2%
9
3%
Non-smoker
6,750
5,680
84%
968
14%
186
3%
146
2%
102
2%
259
4%
Comorbidities
0
5,046
4,530
90%
451
9%
56
1%
40
1%
10
0%
69
1%
1
1,384
1,075
78%
282
20%
54
4%
41
3%
31
2%
72
5%
2
378
231
61%
141
37%
35
9%
33
9%
24
6%
53
14%
3+
230
87
38%
139
60%
47
20%
34
15%
42
18%
74
32%
IBD medication
Sulfasalazine/mesalamine
2,088
1,645
79%
422
20%
82
4%
70
3%
53
3%
119
6%
Budesonide
188
144
77%
42
22%
9
5%
5
3%
6
3%
12
6%
Oral/parenteral steroids
439
277
63%
153
35%
42
10%
30
7%
28
6%
54
12%
6MP/azathioprine monotherapy
594
472
79%
118
20%
28
5%
18
3%
11
2%
35
6%
Methotrexate monotherapy
56
40
71%
14
25%
1
2%
1
2%
3
5%
4
7%
Anti-TNF without 6MP/AZA/MTX
2,307
2,091
91%
188
8%
26
1%
19
1%
11
0%
34
1%
Anti-TNF + 6MP/AZA/MTX
708
602
85%
93
13%
17
2%
12
2%
6
1%
21
3%
Anti-integrin
756
643
85%
97
13%
22
3%
11
1%
9
1%
29
4%
IL 12/23 inhibitor
658
591
90%
54
8%
10
2%
9
1%
5
1%
12
2%
JAK inhibitor
121
104
86%
13
11%
4
3%
1
1%
1
1%
4
3%
Other IBD medication
225
176
78%
45
20%
10
4%
6
3%
5
2%
10
4%
*Medication categories are not mutually exclusive
Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.